EP Patent

EP2932982B1 — A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives

Assigned to Amicus Therapeutics Inc · Expires 2018-10-03 · 8y expired

What this patent protects

Patent listed against migalastat-hydrochloride.

Drugs covered by this patent

migalastat-hydrochloride (MIGALASTAT HYDROCHLORIDE)

Patent Metadata

Patent number: EP2932982B1
Jurisdiction: EP
Classification: —
Expires: 2018-10-03
Drug substance claim: No
Drug product claim: No
Assignee: Amicus Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.